CBG000592 (Riboflavin/Vitamin B2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CBG000592 (Riboflavin/Vitamin B2), covering 2016-10-13 to 2016-10-13. Get the full timeline:
Most recent: Clinical Trial Update: Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke [Phase 2]